top of page
it's where dermatology lives
John Evans
Jan 7, 20222 min read
Combination LAG-3/PD-1 inhibition superior to PD-1 inhibition monotherapy for metastatic melanoma
Findings from a new study suggest that inhibiting both the LAG-3 and PD-1 immune checkpoints in patients with previously untreated...
John Evans
Nov 26, 20211 min read
Post-excision melanoma surveillance by patients effective in small trial
Findings from a pilot trial suggest that after excision of localized melanoma, patient-led surveillance appears to be safe, feasible and...
John Evans
Nov 12, 20212 min read
Available dermatology images and data insufficient to train AI to identify skin cancer
New research published at the NCRI (National Cancer Research Institute) Festival suggests that the images and accompanying data currently...
John Evans
Nov 1, 20211 min read
About 250,000 cases of non-melanoma skin cancer diagnosed in England every year
One in five Brits will develop an NMSC in their lifetime A new study has attempted to stratify the impact of non-melanoma skin cancer...
John Evans
Oct 8, 20211 min read
Rates of non-melanoma skin cancer rising in Ontario
The rates of keratinocyte carcinomas (KCs) in Ontario, Canada increased 30% between 2003 and 2017. These findings come from a paper...
Jeremy Visser
Oct 6, 20211 min read
VIDEO: New research suggests sunlight exposure guidelines may need revisions
Solar exposure guidelines for recommended vitamin D synthesis may need to be revised, according to a new study.
John Evans
Oct 1, 20212 min read
At-home PDT for BCC shows promise in pilot study
A pilot study of a new methyl aminolevulinate (MAL) photodynamic therapy (PDT) device for at-home treatment of basal cell carcinoma (BCC)...
John Evans
Sep 24, 20212 min read
Pembrolizumab lowered risk of stage IIb/c melanoma recurrence
The immunotherapy medication pembrolizumab, approved for the treatment of stage III and IV melanoma, has been shown to reduce...
Featured Posts
bottom of page